Resources » Technical Resource Centers » Protein Technical Resources » Technical Notes
This white paper is a technical resource for scientists who are in the antibody engineering, therapeutics, and development areas of research and are working to optimize their system.
This application note is a free educational and technical resource for scientists in all biomedical disciplines who use proteins or antibodies in their research.
Antigen Production: Selecting the
proper
antigen is one of the most critical steps in a custom antibody project. See what the major factors
that dictate antigen production are.
Learn More »
Recombinant Vaccine: A recombinant
vaccine is a
vaccine generated using recombinant DNA technology. But is that all? Learn about how these vaccines
are produced.
Learn More »
Target Identification:
Target
identification in Antibody Drug Discovery is the process of identifying the molecular target of an
antibody - usually targeting cell surface molecules. See what the detailed steps are.
Learn More »
Antibody Drug Discovery:
Antibody Drug
Discovery is a very large and complex subject. How much do you know? See a simplified overview.
Learn More »
Antibody History: Did you know that the
earliest
reference to antibodies came from Emil von Behring and Shibasabura Kitasato in as early as 1890? Learn
the history of these remarkable molecules.
Learn More »
Antibody Basics: Humans have 5 classes of
Abs - IgG, IgA,
IgD, IgE and IgM. All 5 classes are secreted by activated B cells as glycoproteins. Do you know your
Antibody basics?
Learn More »
Antibody Formats: The modular domain
architecture of full
length IgG has been exploited to create a growing range of alternative antibody formats that spans a
molecular-weight range of at least 12–150 kDa. Explore the other Ab formats.
Learn More »
IgA Antibody: IgA antibody is the most abundant
antibody
class in human serum and has a unique role in mediating immunity. Learn why IgA is so important.
Learn More »
IgM Antibody: IgM antibody characterized by the
µ heavy
chain, is the largest among all antibodies. It is generated as a B cell membrane bound monomer and a
secreted pentamer. Learn about IgM role in disease.
Learn More »
Lead Discovery: Hit generation,
screening, lead
selection, lead optimization and characterization are collectively referred to as "Lead Discovery",
classified under "Late Stage Research" activities.
Learn More »
Lead Selection: Lead selection refers to the process by which the early hits are
interrogated
in a vigorous, multi-step screening process to select lead molecules that meet pre-established
criteria for progressing to the next stage.
Learn More »
Candidate Selection: Clinical candidate selection is a milestone decision
marking a commitment
to advance a therapeutic antibody candidate into clinical trials in human patients.
Learn More »
MBP Tag: MBP tag has been shown to enhance recombinant protein solubility. But
what are the
pros and cons of using the MBP tag?
Learn More »
Microfluidics Cell Culture: Microfluidics technology is characterized by the
manipulation of
small volumes of fluids in channels with dimensions of tens of micrometers. See what the applications
of this technology are.
Learn More »
IgG Antibody: Human IgG antibody is a divalent
antibody and
the most prevalent antibody in serum. It is also at the center stage of antibody drug discovery
efforts. How much do you know about this ubiquitous molecule? Test your knowledge.
Learn More »
Bispecific Antibodies: Bispecific
Antibodies (BsAbs)
are antibodies that can simultaneously bind two separate and unique antigens (or different epitopes of
the same antigen). They are playing an important role in cancer immunotherapy. Learn more about this
remarkable new therapeutic modality.
Learn More »
High Throughput Gene to Antibody Service
Learn MoreMamPower™ Guaranteed Recombinant Antibody Production
Learn MoreHD Transient Expression Service
Learn MoreOur customer service repsentatives are available 24 hours a day, Monday through Friday, to assist you.